Stock Scorer

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Inc. reported revenue of 26K USD for the quarter ending 30 June 2026, up 4.0% from 25K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 26K +4.0%
Gross Profit Q2 '26 · ending 30 June 2026 21K +40.0%
Operating Income Q2 '26 · ending 30 June 2026 -3.5M —
Net Income Q2 '26 · ending 30 June 2026 -3.8M —
Cost of Revenue Q2 '26 · ending 30 June 2026 5K -50.0%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -4.6M —
Free Cash Flow Q4 '24 · ending 31 December 2024 -4M —
Shares Outstanding Q2 '26 · ending 30 June 2026 17.1M +2334.1%
EPS Q2 '26 · ending 30 June 2026 0.01 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 88K-11.7M-14M—
20242024-12-31 170K-19.8M-17.3M-14.9M
20232023-12-31 202K-31.9M-29M—
20222022-12-31 141K-19.9M-19.4M-16.2M
20212021-12-31 135K-18.8M-19.1M-14M
20202020-12-31 163K-15.2M-14.4M-10.4M
20192019-12-31 140K-12.4M-9.4M-9.1M
20182018-12-31 367K-11.5M-9.8M-10.7M
20172017-12-31 437K-11.4M-8.3M-8M
20162016-12-31 92K-13.8M-7.5M-7.5M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-3026K
Q1 '262026-03-3122K
Q4 '252025-12-3121K
Q3 '252025-09-3026K
Q2 '252025-06-3025K
Q1 '252025-03-3116K
Q4 '242024-12-3145K
Q3 '242024-09-3035K
Q2 '242024-06-3050K
Q1 '242024-03-3140K
Q4 '232023-12-3165K
Q3 '232023-09-3046K
Q2 '232023-06-3042K
Q1 '232023-03-3149K
Q4 '222022-12-3156K
Q3 '222022-09-3021K
Q2 '222022-06-3030K
Q1 '222022-03-3133K
Q4 '212021-12-3150K
Q3 '212021-09-3033K

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-3021K
Q1 '262026-03-3118K
Q4 '252025-12-31-19K
Q3 '252025-09-30-42K
Q2 '252025-06-3015K
Q1 '252025-03-316K
Q4 '242024-12-3138K
Q3 '242024-09-3027K
Q2 '242024-06-3042K
Q1 '242024-03-3132K
Q4 '232023-12-3153K
Q3 '232023-09-3016K
Q2 '222022-06-30-39K
Q1 '222022-03-31-44K
Q4 '212021-12-31-126K
Q3 '212021-09-30-124K
Q2 '212021-06-30-256K
Q1 '212021-03-31-209K
Q4 '202020-12-31-156K
Q3 '202020-09-30-168K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-3.5M
Q1 '262026-03-31-2.2M
Q4 '252025-12-31-3M
Q3 '252025-09-30-2.4M
Q2 '252025-06-30-2.6M
Q1 '252025-03-31-3.6M
Q4 '242024-12-31-5.9M
Q3 '242024-09-30-4.5M
Q2 '242024-06-30-3.7M
Q1 '242024-03-31-5.7M
Q4 '232023-12-31-14M
Q3 '232023-09-30-8.2M
Q2 '232023-06-30-5.5M
Q1 '232023-03-31-4.3M
Q4 '222022-12-31-5.6M
Q3 '222022-09-30-6.5M
Q2 '222022-06-30-4.7M
Q1 '222022-03-31-3.2M
Q4 '212021-12-31-7.4M
Q3 '212021-09-30-3.9M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-3.8M
Q1 '262026-03-31-3M
Q4 '252025-12-31-4.2M
Q3 '252025-09-30-3.3M
Q2 '252025-06-30-2.8M
Q1 '252025-03-31-3.7M
Q4 '242024-12-31-6M
Q3 '242024-09-30-3.7M
Q2 '242024-06-30-1.8M
Q1 '242024-03-31-5.8M
Q4 '232023-12-31-12.6M
Q3 '232023-09-30-7.8M
Q2 '232023-06-30-4.9M
Q1 '232023-03-31-3.7M
Q4 '222022-12-31-4.4M
Q3 '222022-09-30-6.4M
Q2 '222022-06-30-4.9M
Q1 '222022-03-31-3.8M
Q4 '212021-12-31-5.8M
Q3 '212021-09-30-3.8M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-305K
Q1 '262026-03-314K
Q4 '252025-12-3140K
Q3 '252025-09-3068K
Q2 '252025-06-3010K
Q1 '252025-03-3110K
Q4 '242024-12-317K
Q3 '242024-09-308K
Q2 '242024-06-308K
Q1 '242024-03-318K
Q4 '232023-12-3112K
Q3 '232023-09-3030K
Q2 '222022-06-3069K
Q1 '222022-03-3177K
Q4 '212021-12-31176K
Q3 '212021-09-30157K
Q2 '212021-06-30279K
Q1 '212021-03-31237K
Q4 '202020-12-31198K
Q3 '202020-09-30204K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-4.6M
Q1 '262026-03-31-2.7M
Q4 '252025-12-31-2M
Q3 '252025-09-30-5.1M
Q2 '252025-06-30-1.5M
Q1 '252025-03-31-2.4M
Q4 '242024-12-31-4M
Q3 '242024-09-30-3.1M
Q2 '242024-06-30-3M
Q1 '242024-03-31-4.8M
Q4 '232023-12-31-9.8M
Q3 '232023-09-30-5.7M
Q2 '232023-06-30-2.2M
Q1 '232023-03-31-3.7M
Q4 '222022-12-31-6.1M
Q3 '222022-09-30-5M
Q2 '222022-06-30-2.3M
Q1 '222022-03-31-2.8M
Q4 '212021-12-31-5.7M
Q3 '212021-09-30-3.5M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '242024-12-31-4M
Q4 '212021-12-31-5.8M
Q3 '212021-09-30-3.5M
Q4 '202020-12-31-2.9M
Q3 '202020-09-30-3M
Q2 '202020-06-30-1.3M
Q1 '202020-03-31-3.3M
Q4 '192019-12-31-2.3M
Q3 '192019-09-30-2.5M
Q2 '192019-06-30-2.8M
Q1 '192019-03-31-1.5M
Q4 '182018-12-31-2.4M
Q4 '172017-12-31-760K
Q3 '172017-09-30-1.9M
Q2 '172017-06-30-2.3M
Q1 '172017-03-31-3M
Q4 '162016-12-31-2.1M
Q3 '162016-09-30-3M
Q4 '152015-12-31-3.3M
Q3 '152015-09-30-3.5M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3017.1M
Q1 '262026-03-314.4M
Q3 '252025-09-302.1M
Q2 '252025-06-30759.3K
Q1 '252025-03-31703.3K
Q3 '242024-09-30576.8K
Q2 '242024-06-30528.4K
Q1 '242024-03-3149.5M
Q3 '232023-09-3048.6M
Q2 '232023-06-3048.4M
Q1 '232023-03-3148.4M
Q3 '222022-09-3048.1M
Q2 '222022-06-3048M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-300.01
Q1 '262026-03-31-3.24
Q4 '242024-12-31-19.04
Q3 '242024-09-30-9.38
Q2 '242024-06-30-3.54
Q1 '242024-03-31-0.64
Q4 '232023-12-31-0.60
Q3 '232023-09-30-0.43
Q2 '232023-06-30-0.40
Q1 '232023-03-31-0.40
Q4 '222022-12-31-0.40
Q3 '222022-09-30-0.43
Q2 '222022-06-30-0.38
Q1 '222022-03-31-0.40
Q4 '212021-12-31-0.40
Q3 '212021-09-30-0.37
Q2 '212021-06-30-0.37
Q1 '212021-03-31-0.36
Q4 '202020-12-31-0.50
Q3 '202020-09-302.12